Therapeutic Modulation of the Nox2–Hv1–ROS Axis by Botulinum Neurotoxin A Confers Protection Against CoCl2-Induced Retinal Hypoxic Injury
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110806 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hey Jin Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: CHA R&D Institute, CHA University, Seongnam 13496, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Cobalt, Reactive Oxygen Species, Botulinum Toxins, Type A, NADPH Oxidase 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Neuroinflammation and oxidative stress are key drivers of various ocular diseases. Experimental hypoxia, modeled using cobalt chloride (CoCl2), induces hypoxia-inducible factor 1-alpha (HIF-1α) stabilization, mitochondrial dysfunction, and excessive reactive oxygen species (ROS) production, primarily via the NADPH oxidase 2 (Nox2)–voltage-gated proton channel Hv1 axis. Although Botulinum neurotoxin type A (BoNT/A) is classically recognized for SNAP-25 cleavage, recent studies suggest broader anti-inflammatory and neuroprotective effects. We evaluated BoNT/A in R28 retinal precursor cells and ex vivo retinal explants subjected to CoCl2-induced hypoxic stress. BoNT/A pretreatment attenuated CoCl2-induced upregulation of HIF-1α, Hv1, Nox2, NOD-like receptor protein 3 (NLRP3), COX2, and nuclear factor kappa B (NF-κB), while enhancing protective mediators including suppressor of cytokine signaling 3 (SOCS3), Growth Associated Protein 43 (Gap43), and Syntaxin12. Brn3a expression and retinal architecture were preserved, apoptotic cell death reduced, and glial activation suppressed. Moreover, BoNT/A decreased mitochondrial ROS accumulation, restored voltage-dependent anion channel 1 (VDAC1) distribution, and partially stabilized intracellular pH. These findings indicate that BoNT/A mitigates oxidative stress and inflammation in hypoxia-driven retinal injury, at least in part, via modulation of the Nox2–Hv1–ROS axis, and support its potential as a therapeutic candidate for ocular disorders associated with hypoxia and neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHA R&D Institute, CHA University, Seongnam 13496, Gyeonggi-do, Republic of Korea.
- Department of Ophthalmology, Bundang CHA Medical Center, CHA University, Seongnam 13496, Gyeonggi-do, Republic of Korea.
- Department of Biomedical Science, CHA University, Seongnam 13496, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Helen Lew
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Lee, H. J., Park, M., Shin, H. A., & Lew, H. (2025). Therapeutic Modulation of the Nox2–Hv1–ROS Axis by Botulinum Neurotoxin A Confers Protection Against CoCl2-Induced Retinal Hypoxic Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110806
Vancouver
Lee HJ, Park M, Shin HA, Lew H. Therapeutic Modulation of the Nox2–Hv1–ROS Axis by Botulinum Neurotoxin A Confers Protection Against CoCl2-Induced Retinal Hypoxic Injury. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110806
BibTeX
@article{Lee2025,
author = {Lee, Hey Jin and Park, Mira and Shin, Hyun-Ah and Lew, Helen},
title = {Therapeutic Modulation of the Nox2–Hv1–ROS Axis by Botulinum Neurotoxin A Confers Protection Against CoCl2-Induced Retinal Hypoxic Injury},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110806}
}
EUVIMED